All articles

Skin & Longevity

Minoxidil:
Topical vs Oral, How It Works and What to Expect

Aevum Protocol10 min read

Minoxidil is the most widely used hair loss treatment in the world, and one of only two with strong evidence for pattern hair loss in both men and women. It was first developed as a blood pressure tablet in the 1970s, when doctors noticed it caused unwanted hair growth. Applied to the scalp as a solution or foam, it lengthens the growing phase of the hair cycle and enlarges shrinking follicles. In a trial of 393 men, the 5% solution produced 45% more regrowth than the 2% solution over 48 weeks. More recently, low-dose minoxidil tablets have become a popular alternative: trials in both men and women show results broadly similar to the topical form, without the daily mess, but with more unwanted body and facial hair and a small risk of effects on blood pressure and fluid balance. Minoxidil isn't a cure. It works best on thinning hair that is still present, takes 6 to 12 months to judge, often causes a temporary increase in shedding at the start, and must be continued: when it's stopped, the hair gained is lost within months. This article compares the forms, explains how to use them and what to expect.

Key numbers

FindingDetail
5% vs 2% solution (393 men, 48 weeks)45% more regrowth with 5%, and faster response
Oral 5 mg vs topical 5% (90 men, 24 weeks)Similar results; slight advantage for oral at the crown
Oral 1 mg vs topical 5% (52 women, 24 weeks)Hair density up 12% vs 7%; difference not significant
Low-dose oral minoxidil safety (1,404 patients)Side effects in 21%; mostly unwanted hair growth (15%)
Stopping oral minoxidil due to side effectsAbout 1.2%
Time to judge results6 to 12 months

How it works

Minoxidil is a "prodrug": it has to be converted into its active form, minoxidil sulfate, by an enzyme called sulfotransferase. This enzyme is found in the outer root sheath of hair follicles and in the liver. Once activated, minoxidil:

The amount of sulfotransferase in scalp follicles varies from person to person, which may explain why some people respond well to topical minoxidil and others don't. In two small studies of 34 men and 21 women, an enzyme test on plucked hairs predicted who would respond to topical minoxidil, correctly classifying about 90% of the women. Because the liver has plenty of this enzyme, oral minoxidil may work for some people who don't respond to the topical form, though the evidence for this is mixed.

Minoxidil doesn't block DHT, the hormone that drives pattern hair loss. That's why it's often combined with a DHT blocker such as finasteride in men (see Finasteride and Dutasteride and Male Pattern Hair Loss).

How minoxidil works: minoxidil applied to the scalp or taken as a tablet is converted by the sulfotransferase enzyme in the follicle or liver into active minoxidil sulfate, which lengthens the growing phase, restarts growth in resting follicles and enlarges shrunken follicles to produce thicker hairs. Minoxidil does not block DHT

The forms compared

FormHow it's usedMain benefitsMain side effectsPrescriptionEvidence
2% solution1 mL to the scalp twice a dayGentler; less facial hair in womenScalp irritation, itchNoStrong
5% solution1 mL twice a day in men; often once a day in womenMore effective than 2%Itch, flaking, irritation from propylene glycol; facial hairNoStrong
5% foamHalf a capful twice a day in men; once a day in womenLess greasy and less irritatingLess irritation than solution; facial hairNoStrong
Low-dose oral tabletUsually 0.5 to 2.5 mg a day in women and 1.25 to 5 mg in menNo daily scalp application; may help topical non-respondersBody and facial hair, ankle swelling, fast heart rate, dizziness, headacheYesModerate to strong
Sublingual tabletDissolved under the tongueMay need lower dosesSimilar to oralYesLimited

What the research shows

Topical minoxidil. Topical minoxidil was approved by the US FDA in 1988, the first medicine proven to regrow hair. In a 48-week trial of 393 men aged 18 to 49, the 5% solution was significantly better than both the 2% solution and placebo, producing 45% more regrowth than 2% and a faster response. Itching and irritation were more common with the 5% solution, but both were well tolerated with no systemic effects. In women, a Cochrane review confirmed that topical minoxidil is effective for female pattern hair loss (see Female Pattern Hair Loss).

Oral minoxidil. Doctors began using low doses of oral minoxidil, a small fraction of the 10 to 40 mg once used for high blood pressure, to treat hair loss in the late 2010s. Two Brazilian randomised trials compared it directly with topical treatment:

The largest safety study, published in 2021, reviewed 1,404 patients treated with low-dose oral minoxidil across 10 centres in six countries, at an average dose of 1.6 mg. Side effects occurred in about 21%, mostly unwanted hair growth (15%). Lightheadedness affected 1.7%, fluid retention 1.3% and fast heart rate 0.9%, and only 1.2% stopped because of systemic side effects.

Topical or oral minoxidil: the topical solution or foam needs no prescription, has strong evidence and few whole-body effects, but needs daily application, can irritate the scalp and can cause facial hair from contact; the low-dose oral tablet is one tablet a day with similar results in trials and may help topical non-responders, but needs a prescription and monitoring, causes more body and facial hair, and carries a small risk of ankle swelling, fast heart rate or dizziness

How to use it

Topical solution or foam.

Oral tablet.

What to expect over time.

Minoxidil, what to expect: a temporary increase in shedding at weeks 2 to 8 is a sign it's working; first fine new hairs at months 2 to 4; time to judge results with photos at months 6 to 12; benefits last only while treatment continues, and stopping loses the gains within months

Safety: who should be careful

Recommendations

By type of hair loss.

Choosing topical or oral.

Practical notes

Minoxidil works best on thinning hair, not on areas that have been bald for years, so start early. Use it consistently, ideally at the same time each day, and give it at least 6 months before judging. Expect a temporary shed in the first two months, and don't stop when it happens. Take photos every 3 months in the same lighting to track progress. Topical minoxidil is available without a prescription; low-dose oral tablets need one, and the small doses used for hair may require tablets to be split or specially prepared. Keep products away from children and pets, and wash your hands after use. If you're considering oral minoxidil, have your blood pressure and heart rate checked first. Our Longevity Doctors can confirm the type of hair loss, help you choose the right form and dose, and monitor safety and progress, starting with the free longevity assessment.

References
  1. Olsen EA, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. Journal of the American Academy of Dermatology, 2002;47(3):377-385.
  2. Penha MA, et al. Oral minoxidil vs topical minoxidil for male androgenetic alopecia: a randomized clinical trial. JAMA Dermatology, 2024;160(6):600-605.
  3. Ramos PM, et al. Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: a randomized clinical trial. Journal of the American Academy of Dermatology, 2020;82(1):252-253.
  4. Vañó-Galván S, et al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. Journal of the American Academy of Dermatology, 2021;84(6):1644-1651.
  5. Goren A, et al.; Roberts J, et al. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil, 2014.
  6. International Society of Hair Restoration Surgery. Minoxidil: formulation, dosage and side effects. ishrs.org.
  7. Navarra Pharmacovigilance Centre and EudraVigilance. Hypertrichosis in infants exposed to topical minoxidil, presented 2024.
  8. Canadian review of minoxidil exposures in cats, Journal of the American Academy of Dermatology; reported in The Limbic, January 2026.
  9. van Zuuren, E.J. et al. Interventions for female pattern hair loss. Cochrane Database of Systematic Reviews, 2012 (updated 2016).

Free longevity assessment

Thinking about starting
minoxidil?

Take the free Aevum Protocol assessment to see how your skin & longevity and 6 other longevity domains are performing — and get a personalised 90-day plan.

Take the free assessment